Nursing care for older people with advanced cancer who live alone during outpatient chemotherapy should address their difficulties while respecting their lives. However, their lived experiences remain underexplored. Therefore, we conducted a descriptive qualitative study to explore and describe their lives. The participants were purposively sampled, older patients (≥ 65 years) with advanced cancer who lived alone and were receiving outpatient cancer chemotherapy. Semi-structured interviews were conducted using an interview guide, and thematic analysis was applied. There were 12 participants. Nine categories and 49 subcategories were extracted. The core category was "Getting by through endurance, ingenuity, and effort in one's increasingly fragile 'own vessel,' in order to survive a little longer and fulfill one's life." Effective support should not only address their challenges, but also respect their convictions, leverage their strengths, and enhance their self-efficacy. Further, early implementation of advance care planning (ACP) is crucial to proactively identify the needs of these patients, who rarely express their concerns. This approach facilitates their transition from full independence to autonomy, enabling them to choose and integrate necessary support into their daily lives.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/nhs.70076 | DOI Listing |
Thorac Cancer
March 2025
Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan.
Background: Bone metastasis (BoM) is common in advanced cancer, but its incidence in pleural mesothelioma (PM) remains unclear. This study aimed to determine the incidence of BoM in PM patients and assess its prognosis and risk factors to clarify its clinical significance.
Methods: A retrospective analysis was conducted on 515 histologically confirmed PM patients enrolled between January 2011 and December 2020.
Background: The development of immunotherapy has led to a paradigm shift in the treatment of malignant tumors. Immune checkpoint inhibitors (ICIs) function by blocking the receptors and ligands of T cells from binding one another, empowering them to target and attack cancer cells. ICIs along with other immunotherapy treatments, have seen a significant increase in usage in recent years.
View Article and Find Full Text PDFHealth Sociol Rev
March 2025
Department of Health, VIVE - The Danish Center for Social Science Research, Copenhagen, Denmark.
Integrating palliative care into the trajectories of patients with incurable cancer has been a priority for years. Yet, the intended outcomes of this integration remain elusive. Many patients with advanced cancer continue to receive so-called aggressive treatments in the end-of-life phase or miss out on specialised palliative care entirely.
View Article and Find Full Text PDFFront Immunol
March 2025
Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University (Changhai Hospital of Shanghai), Shanghai, China.
Immunotherapy has brought better survival benefits in the treatment of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, owing to the lack of relevant biomarkers that could predict the efficacy of this treatment, it often has to be maintained. Here we report on a patient with stage IVA squamous cell carcinoma of the tongue who developed an unresectable lesion in the neck after surgery and radical chemoradiotherapy.
View Article and Find Full Text PDFFront Immunol
March 2025
Biotech Research and Innovation Center (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!